Tag: Apeiron

EU approves first immunotherapy for neuroblastoma

by Selina McKee | May 10, 2017 | News | 0

EU regulators have issued a green light for the first immunotherapy for high-risk neuroblastoma, offering thousands of children affected by the rare and devastating form of cancer a new treatment option.

Six new medicines backed for EU approval

by Selina McKee | Mar 27, 2017 | News | 0

Six new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).